Cleared Traditional

K841303 - CAMPYLOBACTER THIOGLYCOLLATE MED

K841303 is the FDA 510(k) clearance for CAMPYLOBACTER THIOGLYCOLLATE MED by Anaerobe Systems. It is a Class 1 Microbiology device (product code JSG) cleared through the Traditional 510(k) pathway after a 18-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1984
Decision
18d
Days
Class 1
Risk

K841303 is an FDA 510(k) clearance for the CAMPYLOBACTER THIOGLYCOLLATE MED. Classified as Culture Media, Non-selective And Non-differential (product code JSG), Class I - General Controls.

Submitted by Anaerobe Systems (Mchenry, US). The FDA issued a Cleared decision on April 17, 1984 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2300 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Anaerobe Systems devices

Submission Details

510(k) Number K841303 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 1984
Decision Date April 17, 1984
Days to Decision 18 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 102d · This submission: 18d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JSG Culture Media, Non-selective And Non-differential
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2300
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JSG Culture Media, Non-selective And Non-differential

All 175
Devices cleared under the same product code (JSG) and FDA review panel - the closest regulatory comparables to K841303.
BIOTIS SCHAEDLER AGAR & BROTH
K843764 · Otisville Biotech, Inc. · Oct 1984
MAXIMUM RECOVERY DILUENT
K841662 · Oxoid U.S.A., Inc. · Jun 1984
BIPHASIC BLOOD CULTURE BOTTLE
K842036 · Gibco Laboratories Life Technologies, Inc. · Jun 1984
COLUMBIA AGAR W/5% SHEEP BLOOD
K841143 · Anaerobe Systems · Mar 1984
CHOCOLATE AGAR W/COFACTOR
K841144 · Anaerobe Systems · Mar 1984
TRYPTICASE SOY AGAR W/5% SHEEP BLOOD
K841130 · Anaerobe Systems · Mar 1984